VEGFA and cancer: Similarly, expression of VEGF, an index related to clinical outcome in cancer patients [24], in the B16–F10 xenografts of mice that were administered 25 mg/kg roxarsone was significantly higher than that of untreated mice; this was also observed in our western blot results (Fig. 8B).